Cytokines and anticytokines in the pathogenesis of sepsis (Q33642551)

28 July 2017

1 reference

title

Cytokines and anticytokines in the pathogenesis of sepsis (English)

1 reference

28 July 2017

0 references

0 references

van der Poll T

1

1 reference

PubMed ID

10340175

28 July 2017

van Deventer SJ

series ordinal

2

1 reference

28 July 2017

1 June 1999

1 reference

Infectious Disease Clinics of North America

28 July 2017

1 reference

28 July 2017

13

1 reference

28 July 2017

413-26, ix

1 reference

28 July 2017

2

1 reference

Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Sepsis: a new hypothesis for pathogenesis of the disease process

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interferon gamma receptor deficient mice are resistant to endotoxic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Compartmentalized cytokine production within the human lung in unilateral pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Perioperative pattern of peritoneal interleukin 8, tumour necrosis factor-alpha, and granulocyte elastase release in human secondary peritonitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

1 reference

7 January 2021

Dysregulation of in vitro cytokine production by monocytes during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-12 in infectious diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Role of Interferon- in Experimental Gram-Negative Sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-10 impairs host defense in murine pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970083-0

7 January 2021

10.1016/S0891-5520(05)70083-0

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10340175